These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8001709)

  • 61. Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model.
    Mah-Becherel MC; Céraline J; Deplanque G; Chenard MP; Bergerat JP; Cazenave JP; Klein-Soyer C
    Br J Cancer; 2002 Mar; 86(5):803-10. PubMed ID: 11875746
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Preventive treatment of diabetic microangiopathy: blocking the pathogenic mechanisms].
    Guillausseau PJ
    Diabete Metab; 1994; 20(2 Pt 2):219-28. PubMed ID: 8001709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevention of long-term complications of non-insulin-dependent diabetes mellitus.
    Nathan DM
    Clin Invest Med; 1995 Aug; 18(4):332-9. PubMed ID: 8549021
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Microangiopathy in diabetes mellitus: I. Causes, prevention and treatment.
    Chittenden SJ; Shami SK
    Diabetes Res; 1991 Jul; 17(3):105-14. PubMed ID: 1841026
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biochemical and vascular factors in the pathogenesis of diabetic neuropathy.
    Ward JD
    Clin Invest Med; 1995 Aug; 18(4):267-74. PubMed ID: 8549012
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

  • 68. New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition.
    Hotta N
    Nagoya J Med Sci; 1997 Nov; 60(3-4):89-100. PubMed ID: 9481088
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Role of polyol pathway in pathogenesis of diabetic microangiopathy].
    Nakamura J
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():52-61. PubMed ID: 15999685
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.